Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$22,346,820
-$28,728 QoQ
Shares Held
87,990
-3.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.96%
of 13F equity value
Holder Rank
#701
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Violich Capital Management, Inc. holds $62,484,887 across 7 Drug Manufacturers - General names. JNJ ranks #2 (35.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
109,254 | $27,492,676 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
87,990 | $22,346,820 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,257 | $6,458,024 | |
| 4 | AMGN |
Amgen Inc
|
9,350 | $3,385,822 | |
| 5 | LLY |
ELI LILLY & Co
|
1,291 | $1,548,464 | |
| 6 | PFE |
Pfizer Inc
|
26,350 | $634,508 | |
| 7 | NVS |
Novartis AG
|
3,947 | $618,573 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,346,820 | 87,990 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $22,375,548 | 91,538 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $19,461,164 | 94,038 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $17,751,369 | 95,736 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $13,493,324 | 88,336 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $16,706,721 | 100,740 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $14,493,382 | 100,217 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $15,829,696 | 97,678 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $14,195,205 | 97,121 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $15,302,667 | 96,736 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $14,510,048 | 92,574 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $14,692,520 | 94,334 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $17,426,442 | 105,283 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $16,507,965 | 106,503 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $18,813,754 | 106,503 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $17,563,977 | 107,517 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $19,080,194 | 107,488 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $19,019,260 | 107,314 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $18,426,120 | 107,711 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $17,600,916 | 108,984 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $17,631,133 | 107,024 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $17,875,363 | 108,764 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $16,798,583 | 106,739 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $15,890,557 | 106,734 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $16,084,415 | 114,374 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $14,889,680 | 113,549 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||